Sabon bincike ya nuna cewa a marasa lafiya tare da hanta ko hanta mai rinjaye cututtukan fata na fata , Bugu da ƙari na zaɓin maganin radiation na ciki zuwa daidaitattun layin farko na mFOLFOX6 chemotherapy yana haifar da karuwa mai yawa a cikin rayuwar marasa lafiya tare da ciwace-ciwacen farko a dama.
SIRT, wanda aka yi amfani da shi a Turai tun 2003, shine radiotherapy na ciki ta yin amfani da Y-90 resin microspheres (diamita tsakanin 20 zuwa 60 microns) isar da shi a cikin jijiyoyin hanta ta amfani da catheter . Beta radiation emitting microspheres an sanya su a cikin microvessels kewaye da ƙari, rage tasirin tsarin.
Karatuttukan duniya na SIRFLOX, FOXFIRE da FOXFIRE da nufin kimanta inganci da amincin SIRT tare da layin farko na oxaliplatin chemotherapy don mCRC da ba za a iya tantance shi ba.
Ga marasa lafiya 554 da suka sami chemotherapy tare da SIRT da kuma 549 marasa lafiya wadanda suka karbi maganin kawai, sakamakon ya nuna cewa lokacin rayuwa na tsakiyar hagu na hagu na marasa lafiyar mCRC a cikin cutar sankara tare da kungiyar SIRT shine watanni 24.6, idan aka kwatanta da watanni 26.6 a cikin kungiyar kadai ta jiyyar cutar sankara. , amma SIRT chemotherapy Rayuwa ta tsakiya na marasa lafiya na mCRC tare da ciwace-ciwacen da ke gefe ɗaya shi ne watanni 22 a cikin rukuni da kuma watanni 17.1 a cikin ƙungiyar ƙera ƙwayoyin cuta ita kaɗai, wanda ya fi watanni 5 ya fi tsayi.
A wani taron manema labarai, Dakta Harpreet Wasan ya fada wa Imperial College Health Care NHS Trust a Burtaniya cewa wani hasashe shi ne cewa cutar daji ta dama ba kawai […] ta munana ba amma ta fi jurewa da cutar sankara. Suna iya zama masu saurin kulawa da maganin radiation, wanda ke da tsarin aiki daban daban.
Dokta Wasan ya kara da cewa rashin kyakkyawan sakamako a cikin binciken na iya kasancewa saboda hada marasa lafiya da ke fama da cutar kansa a hanta. Ya ce: "Duk da cewa SIRT na iya magance cututtukan hanta, ba za ta iya sarrafa cututtukan da ke wajen hanta ba."
